It remains to be tested if variants in other populations also contribute to lung cancer susceptibility, or if L2307F co-occurring with other clearly pathogenic ATM mutations increases lung cancer risk beyond that experienced by heterozygotes. This evidence concerns the gene ATM and lung carcinoma.